PT  - JOURNAL ARTICLE
AU  - Faust, Jeremy S.
AU  - Du, Chengan
AU  - Mayes, Katherine Dickerson
AU  - Li, Shu-Xia
AU  - Lin, Zhenqiu
AU  - Barnett, Michael L.
AU  - Krumholz, Harlan M.
TI  - Mortality from injury, overdose and suicide during the 2020 COVID-19 pandemic, March-July, 2020
AID  - 10.1101/2021.02.13.21251682
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.13.21251682
4099  - http://medrxiv.org/content/early/2021/02/16/2021.02.13.21251682.short
4100  - http://medrxiv.org/content/early/2021/02/16/2021.02.13.21251682.full
AB  - IntroductionThe COVID-19 pandemic has been associated with substantial rates of all-cause excess mortality. The contribution of external causes of death to excess mortality including drug overdose, homicide, suicide, and unintentional injuries during the initial outbreak in the United States is less well documented.Methods Using public data published by the National Center for Health Statistics on February 10, 2021, we measured monthly excess mortality (the gap between observed and expected deaths) from five external causes using national-level data published by National Center for Health Statistics; assault (homicide); intentional self-harm (suicide); accidents (unintentional injuries); and motor vehicle accidents. We used seasonal autoregressive integrated moving average (sARIMA) models developed with cause-specific monthly mortality counts and US population data from 2015-2019 and estimated the contribution of individual cause-specific mortality to all-cause excess mortality from March-July 2020.Results From March-July, 2020, 212,825 (95% CI 136,236-290,776) all-cause excess deaths occurred in the US). There were 8,540 excess drug overdoses (all intents) (95% CI 5,106 to 11,975), accounting for 4% of all excess mortality; 1,455 excess homicide deaths (95% CI 708 to 2202, accounting for 0.7% of excess mortality; 5,492 excess deaths due to unintentional accidents occurred (95% CI 85 to 10,899, accounting for 2.6% of excess mortality. Though a non-significantly 135 (95% CI -1361 to 1,630) more MVA deaths were recorded during the study period, a significant decrease in April (525; 95% CI -817 to -233) and significant increases in June-July (965; 95% CI 348 to 1,587) were observed. Suicide deaths were statistically lower than projected by 2,067 (95% CI 941-3,193 fewer deaths).Meaning Excess deaths from drug overdoses, homicide, and addicents occurred during the pandemic but represented a small fraction of all-cause excess mortality. The excess external causes of death, however, still represent thousands of lives lost. Notably, deaths from suicide were lower than expected and therefore did not contribute to excess mortality.Competing Interest StatementFunding Statements: Faust: None. Du: None. Mayes: None. Li: None. Lin: Dr Lin reported working under contract with the Centers for Medicare & Medicaid Services. Barnett: Dr Barnett reported being retained as an expert witness by government plaintiffs in lawsuits against opioid manufacturers. No other disclosures were reported. Krumholz: In the past three years, Dr Krumholz received expenses and/or personal fees from UnitedHealth, IBM Watson Health, Element Science, Aetna, Facebook, the Siegfried and Jensen Law Firm, Arnold and Porter Law Firm, Martin/Baughman Law Firm, F-Prime, and the National Center for Cardiovascular Diseases in Beijing. He is an owner of Refactor Health and HugoHealth, and had grants and/or contracts from the Centers for Medicare & Medicaid Services, Medtronic, the U.S. Food and Drug Administration, Johnson & Johnson, and the Shenzhen Center for Health Information. Funding StatementThis study had no specific funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used publicly available data and was not subject to institutional review approval and adhered to STROBE guidelines.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDr. Faust had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The data are available to the public.